Back
Open Access

Conclusion.

Session: SGLT2 inhibition across the spectrum of heart failure: maximizing patient benefits in clinical practice
Topic: Chronic Heart Failure
Speaker: Professor C. Lam (Singapore, SG)
Organised by Charité Friends & Sponsors Trust
Event: Heart Failure 2022

Congress Presentation

About the speaker

Professor Carolyn Sp Lam

National Heart Centre Singapore, Singapore (Singapore)
146 presentations
49 followers

5 more presentations in this session

Welcome and introduction.

Speaker: Professor S. Anker (Berlin, DE)

Access
Slides
Video
Thumbnail

Optimizing foundational therapies in HF ‒ can we do better?

Speaker: Professor A. Coats (Coventry, GB)

Access
Slides
Video
Thumbnail

SGLT2 inhibition ‒ early, first-line therapy across the spectrum of HF.

Speaker: Doctor D. Tomasoni (Brescia, IT)

Access
Slides
Video
Thumbnail

SGLT2 inhibition in patients with HFpEF ‒ a case-based discussion.

Speaker: Professor G. Rosano (London, GB)

Access
Slides
Video
Thumbnail

Interactive panel discussion.

Speaker: Professor S. Anker (Berlin, DE) Professor A. Coats (Coventry, GB) Doctor D. Tomasoni (Brescia, IT) Professor G. Rosano (London, GB)

Access
Video
Thumbnail

Access the full session

SGLT2 inhibition across the spectrum of heart failure: maximizing patient benefits in clinical practice

Speakers: Professor C. Lam, Professor S. Anker, Professor A. Coats, Doctor D. Tomasoni, Professor G. Rosano...
Access
Video
Thumbnail

About the event

Image

Heart Failure 2022

21 May - 24 May 2022

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb